DR. DAVID N CHERNOFF, MD
Osteopathic Medicine at Bret Harte Rd, San Rafael, CA
License number
California G49518
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
550 Bret Harte Rd, San Rafael, CA 94901
Phone
(415) 459-6601
(415) 459-6602 (Fax)
(415) 459-6602 (Fax)
Professional information
Methods And Compositions For The Treatment Of Viral Infections
US Patent:
2010016, Jun 24, 2010
Filed:
Aug 20, 2009
Appl. No.:
12/545007
Inventors:
Gregory Went - Mill Valley CA, US
David Chernoff - San Rafael CA, US
Paul Spence - Mill Valley CA, US
Terry Burkoth - Palo Alto CA, US
Timothy Fultz - Pleasant Hill CA, US
David Chernoff - San Rafael CA, US
Paul Spence - Mill Valley CA, US
Terry Burkoth - Palo Alto CA, US
Timothy Fultz - Pleasant Hill CA, US
International Classification:
A61K 31/215, A61K 31/13, A61P 31/16
US Classification:
514529, 514662
Abstract:
Compositions for treating flu comprise an M2 inhibitor, and optionally a neuraminidase inhibitor, wherein at least one of said M2 inhibitor or said neuraminidase inhibitor is provided in an extended release dosage form.
Compositions And Kits For Treating Influenza
US Patent:
7981930, Jul 19, 2011
Filed:
Feb 29, 2008
Appl. No.:
12/040856
Inventors:
Jack Nguyen - San Francisco CA, US
Gregory T. Went - Mill Valley CA, US
Paul Spence - Mill CA, US
Timothy J. Fultz - Pleasant Hill CA, US
David Chernoff - San Rafael CA, US
Terry L. Burkoth - Palo Alto CA, US
Rowan Chapman - Burlingame CA, US
Mickey S. Urdea - Alamo CA, US
Gregory T. Went - Mill Valley CA, US
Paul Spence - Mill CA, US
Timothy J. Fultz - Pleasant Hill CA, US
David Chernoff - San Rafael CA, US
Terry L. Burkoth - Palo Alto CA, US
Rowan Chapman - Burlingame CA, US
Mickey S. Urdea - Alamo CA, US
Assignee:
Adamas Pharmaceuticals, Inc. - Emeryville CA
International Classification:
A61K 31/7056, A61K 31/351, A61K 31/215, A61K 31/196, A61K 31/195, A61K 31/131, C07H 19/056, C07D 309/28, C07C 69/75, C07C 61/22, C07C 229/48, C07C 211/38
US Classification:
514529, 514629, 514 43, 514659, 514661, 514662, 514459, 514563, 536 287, 549424, 560128, 562507, 564456, 564458, 564459
Abstract:
Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin, and a neuraminidase inhibitor (NAi) in an amount that is antivirally effective in the combination, an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin and a neuraminidase inhibitor are provided for the treatment of influenza. Some embodiments of the kits comprise an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin, and a neuraminidase inhibitor.
Compositions And Kits For Treating Influenza
US Patent:
2011023, Sep 22, 2011
Filed:
May 26, 2011
Appl. No.:
13/116484
Inventors:
Jack Nguyen - San Francisco CA, US
Gregory T. Went - Mill Valley CA, US
Paul Spence - San Diego CA, US
Timothy J. Fultz - Pleasant Hill CA, US
David Chernoff - San Rafael CA, US
Gregory T. Went - Mill Valley CA, US
Paul Spence - San Diego CA, US
Timothy J. Fultz - Pleasant Hill CA, US
David Chernoff - San Rafael CA, US
Assignee:
Adamas Pharmaceuticals, Inc. - Emeryville CA
International Classification:
A61K 31/7056, A61P 31/16
US Classification:
514 43
Abstract:
Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.